1007-3418
2015 Issue 2
What's new in 2014 for treatment of hepatitis C
Huang Rui;,Wei Lai;
Huang Rui;,Wei Lai;
..............page:81-85
Advances in clinical research on non-infectious liver diseases in 2014
Hao Ruirui;,Jia Jidong;
Hao Ruirui;,Jia Jidong;
..............page:86-89
Advances in research on hepatocellular carcinoma in 2014
Ye Shenglong;
Ye Shenglong;
..............page:90-93
Decrease in γδV 2 T cells correlates with severity of liver injury and fibrosis in patients with chronic hepatitis B
Li Yuanyuan;,Wu Xiaoli;,Chen Liming;,Lyu Sha;,Zhang Jiyuan;,Wang Fusheng;
Li Yuanyuan;,Wu Xiaoli;,Chen Liming;,Lyu Sha;,Zhang Jiyuan;,Wang Fusheng;
..............page:94-98
Impact of liver steatosis on the curative effect of pegylated interferon-aipha-2a in patients with chronic hepatitis B
Xu Liang;,Li Ping;,Shi Qiyu;,Mi Yuqiang;
Xu Liang;,Li Ping;,Shi Qiyu;,Mi Yuqiang;
..............page:99-102
Comparison of FibroTouch and FibroScan for the assessment of fibrosis in chronic hepatitis B patients
ou xiao juan ;, wang xiao ming ;, wu xiao ning ;, kong zuo zuo ;, duan wei jia ;, zhou jia ling ;, sun dong yang ;, wang yu ;, you hong ;
ou xiao juan ;, wang xiao ming ;, wu xiao ning ;, kong zuo zuo ;, duan wei jia ;, zhou jia ling ;, sun dong yang ;, wang yu ;, you hong ;
..............page:103-106
Evaluation methods of angiogenesis in experimental liver fibrosis
Zhao Zhimin;,Guo Tao;,Yang Shuohui;,Pan Kai;,Tan Ye;,Chen Gaofeng;,Liu Chenghai;
Zhao Zhimin;,Guo Tao;,Yang Shuohui;,Pan Kai;,Tan Ye;,Chen Gaofeng;,Liu Chenghai;
..............page:107-111
Effects of hypoxia inducible factor-2α on promoting angiogenesis of residual hepatocellular carcinoma after high-intensity focused ultrasound ablation
Wu Lun;,Zhou Wenbo;,Zhou Shiji;,Liu Chang'an;,Li Shengwei;
Wu Lun;,Zhou Wenbo;,Zhou Shiji;,Liu Chang'an;,Li Shengwei;
..............page:112-117
Unilateral versus bilateral biliary drainage for malignant hilar obstruction: a systematic review and meta-analysis
Li Mingwu;,Wu Wenbin;,Yin Zhanxin;,Han Guohong;
Li Mingwu;,Wu Wenbin;,Yin Zhanxin;,Han Guohong;
..............page:118-123
Effect of apigenin on protein expressions of PPARs in liver tissues of rats with nonalcoholic steatohepatitis
Shi Tingting;,Zhuang Rangxiao;,Zhou Hongping;,Wang Fugen;,Shao Yidan;,Cai Zhaobin;
Shi Tingting;,Zhuang Rangxiao;,Zhou Hongping;,Wang Fugen;,Shao Yidan;,Cai Zhaobin;
..............page:124-129
GLP-1 receptor activation effects the p38MAPK signal pathway in hepatic stellate cells
Wu Lingkang;,Li Youming;,Liu Yingchao;,Tang Cuilan;,Wu Feng;,Shi Liangliang;,Lu Keda;
Wu Lingkang;,Li Youming;,Liu Yingchao;,Tang Cuilan;,Wu Feng;,Shi Liangliang;,Lu Keda;
..............page:130-133
Clinical efficacy of modified TIPS or percutaneous transhepatic portal vein paracentesis interventional therapy for portal vein thrombosis
Cai Yuefei;,Ma Yanhua;,Tan Xiaoming;,Zhong Sheng;,Wang Youzhi;,Xian Chongyang;
Cai Yuefei;,Ma Yanhua;,Tan Xiaoming;,Zhong Sheng;,Wang Youzhi;,Xian Chongyang;
..............page:134-136
Total flavone from Litchi chinensis Sonn interferes with nuclear factor-κB in bile duct ligation-induced cholestasis rats
zhao yong zhong ;, cheng qiu zuo ;, lu qing ;, xiao xu hua ;, huang da jian ;, liu rui biao ;, li sheng lian ;, dong yong ;
zhao yong zhong ;, cheng qiu zuo ;, lu qing ;, xiao xu hua ;, huang da jian ;, liu rui biao ;, li sheng lian ;, dong yong ;
..............page:137-139
Effects of Shuganjianpi formula on the serum metabonomic profile in CCl4-induced hepatic fibrosis rats
Jiang Hui;,Wu Furong;,Gao Jiarong;,Chen Jinfeng;
Jiang Hui;,Wu Furong;,Gao Jiarong;,Chen Jinfeng;
..............page:139-141
Correlation between hepatitis C genotype, viral load, and peripheral blood T lymphocyte subsets in patients from the Kunming area
li zuo lin ;, bi sheng ;, gao yu hong ;, li zuo ;, zhu hong yan ;, xia xue shan ;, feng yue ;, xu yong min ;
li zuo lin ;, bi sheng ;, gao yu hong ;, li zuo ;, zhu hong yan ;, xia xue shan ;, feng yue ;, xu yong min ;
..............page:142-144
A case report of abnormal liver function induced by myofibroblastic sarcoma infiltrating the liver
Ou Hongjie;,Pan Ye;,Wu Xiaolu;,Liu Jiajun;
Ou Hongjie;,Pan Ye;,Wu Xiaolu;,Liu Jiajun;
..............page:144-145
A report from the Forth Chinese National Symposium on Liver Fibrosis and Cirrhosis
Ma Hong;,Xu Xiaoyuan;
Ma Hong;,Xu Xiaoyuan;
..............page:146
Recent progress in the risk factors for development of hepatocellular carcinoma in patients with primary biliary cirrhosis
Zhang Xuexiu;,Wang Lifeng;,Jin Lei;,Wang Fusheng;
Zhang Xuexiu;,Wang Lifeng;,Jin Lei;,Wang Fusheng;
..............page:147-149
The progress on acoustic radiation force impulse imaging for non-invasive diagnosis of liver fibrosis
Yang Xiaoxiao;,Ma Hong;,Wang Yu;
Yang Xiaoxiao;,Ma Hong;,Wang Yu;
..............page:150-153
Application and development of C-arm computed tomography as a diagnostic and minimally-invasive therapy for liver malignant tumors
Liang Weiren;,Min Jie;,Li Bin;,Zhang Guangqiang;,Chao Ming;
Liang Weiren;,Min Jie;,Li Bin;,Zhang Guangqiang;,Chao Ming;
..............page:154-157
Progress in identification and characterization of serum protein markers of hepatocellular carcinoma
Zhang Tao;,Qin Xiaofeng;,Cheng Genhong;
Zhang Tao;,Qin Xiaofeng;,Cheng Genhong;
..............page:158-160